Zeke Capital Advisors, LLC Eli Lilly & CO Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 5,442 shares of LLY stock, worth $4.33 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,442

Previous 4,064 33.91%

Holding current value

$4.33 Million

Previous $1.31 Million 51.45%

% of portfolio

0.13%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $443,095 - $516,295	1,378 Added 33.91%	5,442 $1.99 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.02%	4,064 $1.31 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $45,711 - $53,672	164 Added 4.21%	4,063 $1.32 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $915,056 - $1.14 Million	3,899 New	3,899 $1.12 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $225,638 - $271,553	-1,654 Closed	0 $0
Q1 2020 Apr 24, 2020	SELL	$119.05 - $147.35 $1.31 Million - $1.62 Million	-10,968 Reduced 86.9%	1,654 $229,000
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $70,887 - $87,801	-663 Reduced 4.99%	12,622 $1.66 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $27,551 - $29,969	258 Added 1.98%	13,285 $1.49 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $340,346 - $397,271	-3,072 Reduced 19.08%	13,027 $1.44 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $1.16 Million - $1.37 Million	-10,436 Reduced 39.33%	16,099 $2.09 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $1.5 Million - $1.68 Million	-14,184 Reduced 34.83%	26,535 $3.07 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $25,758 - $32,193	300 Added 0.74%	40,719 $4.37 Million
Q2 2018 Jul 24, 2018	BUY	$75.7 - $86.88 $972,972 - $1.12 Million	12,853 Added 46.63%	40,419 $3.45 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $141,370 - $166,878	1,905 Added 7.42%	27,566 $2.13 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $148,721 - $159,520	1,815 Added 7.61%	25,661 $2.17 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $1.84 Million - $2.04 Million	23,846	23,846 $2.04 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Eli Lilly & CO Transaction History